AddedRisk Factors
In addition to the federal healthcare program changes under the OBBBA, the enhanced premium tax credits, originally enacted under the American Rescue Plan Act of 2021, expired on December 31, 2025. Consequently, marketplace premiums have increased substantially, and enrollment for the 2026 plan year declined significantly. This increases the likelihood that more patients are uninsured, underinsured, or may become uninsured or underinsured. An increase in uninsured or underinsured patients or a deterioration in the collectability of patient accounts receivable could have a material adverse effect on our business, financial condition and results of operations.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedRisk Factors
If the rates paid or the scope of services covered by government payors are reduced, there could be a material adverse effect on our business, financial condition and results of operations.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedRisk Factors
Healthcare policy changes that increase the number of uninsured patients may adversely affect our results of operations. For example, the OBBBA reduces federal Medicaid expenditures and imposes more stringent Medicaid eligibility requirements. By December 31, 2026, Medicaid expansion states will also be required to conduct eligibility redeterminations at least every six months. These changes increase the likelihood of coverage loss, including mid‑year loss of eligibility, which may disrupt treatment continuity, complicate coverage verification processes, and result in higher levels of uncompensated care and uncollected patient balances. In addition, the enhanced premium tax credits for ACA marketplace health plans, enacted under the American Rescue Plan Act of 2021, expired on December 31, 2025. Following the expiration of these subsidies, marketplace premiums increased substantially and enrollment for the 2026 plan year declined significantly, increasing the likelihood that patients who previously maintained coverage may no longer be insured.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedRisk Factors
Some companies that have experienced volatility in the market price of their stock, including us, have been subject to securities class action litigation. We have been the target of this type of litigation and may continue to be a target in the future. Securities litigation against us has, and could in the future, result in substantial costs and divert our management’s attention from other business concerns, which could materially adversely affect our business, results of operations, and financial condition. For example, during the year ended December 31, 2025, we incurred $147.5 million of settlement expense for the 2019 Securities Litigation (as described in more detail in Note 11 — Commitments and Contingencies in the accompanying notes to our consolidated financial statements).
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RemovedRisk Factors
Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies — Goodwill and Indefinite-Lived Intangible Assets” for additional information.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RemovedRisk Factors
impact on our business, financial position, results of operations and cash flows. Inflation has also resulted in higher interest rates, which in turn will result in higher costs of debt borrowing and could limit our growth strategy.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RewordedRisk Factors
For example, as on July 7, 2023, in connection with one of the lawsuits in our Desert Hills Litigation (as described in more detail in Note 11 — Commitments and Contingencies in the accompanying notes to our consolidated financial statements, on July 7, 2023, in connection with one of the lawsuits in our Desert Hills Litigation, statements), a jury awarded the plaintiff compensatory damages of $80.0 million and punitive damages of $405.0 million.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
We are subject to volatility in the global capital and credit markets as well as significant developments in macroeconomic and political conditions that are out of our control. control, including any effects that a U.S. government shutdown, tariffs or trade disputes may have on financial markets and macroeconomic conditions.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
At December 31, 2024, 2025, we had approximately $2.0 $2.5 billion of total debt (net of debt issuance costs, discounts and premiums of $8.9 $16.8 million), which included approximately $1.0 billion of debt under the Credit Facility, $450.0 million of debt under the 5.500% Senior Notes (as defined below) and below), $475.0 million of debt under the 5.000% Senior Notes (as defined below). below), and $550.0 million of debt under the 7.375% Senior Notes.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, certain of our facilities are required to maintain specified staffing levels. levels, including minimum staff- or nurse-to-patient staffing ratios applicable to our facilities located in California, which increases our labor costs.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
For example, the federal government and some states impose laws governing the use and disclosure of health information pertaining to mental health and/or substance abuse treatment that are more stringent than the rules that apply to healthcare information generally.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
For the year ended December 31, 2024, 2025, we recorded non-cash impairment charges of $17.3 million related to the closure of certain facilities, $1,007.9 million, which is recorded in loss on impairment in our consolidated statement of operations.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
The expertise and efforts of our senior executives executives, including our Chief Executive Officer and the chief executive officer, chief financial officer, Chief Financial Officer, medical directors, physicians and other key members of our facility management personnel are important to the success of our business.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our business has in the past been, and may continue to be, affected by a number of factors that are beyond our control, such as general macroeconomic conditions, conditions in the financial services markets, geopolitical conditions and other general political and economic developments, developments (including a U.S. government shutdown or the imposition of tariffs or trade disputes), and can continue to be affected by such factors in the future.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
Current and future inflationary effects may be driven by, among other things, supply chain disruptions and governmental stimulus or fiscal policies, and geopolitical instability, including the ongoing conflicts between Ukraine and Russia and in Israel and Gaza. instability.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
We depend on key management personnel, and the departure of failure to attract and retain one or more of our key executives executives, including our Chief Executive Officer, or a significant portion of our local facility management personnel could harm our business.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
Failure to comply with the hospital price transparency regulations may result in corrective action or civil monetary penalties.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedRisk Factors
Continuing inflationary pressure, has in the past, and could in the future, impact our costs of labor and services and the margins we are able to realize on the operation of our facilities and services, all of which could have an adverse impact on our business, financial position, results of operations and cash flows.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
Quiet changesRisk Factors
It If hired, it may take time for new officers to be integrated into our business.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
•our dependence on key management personnel, key executive and local facility management personnel, the failure to attract and retain such personnel, including our Chief Executive Officer, and the impact of any disruptions from the recent transition of various executives;
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
•the impact from changes in expectations resulting from actuarial and other reviews of our liability reserves and other aspects of our business;
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
•the impact of the restructuring, consolidation, and elimination of federal agencies that regulate the healthcare industry, which could result in changes to federal agency reviews and enforcement activities, priorities, and guidance, and has the potential to cause delays in obtaining necessary or desired reviews and approvals for our facilities;
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
•the impact of various executive orders affecting the broader healthcare industry; and
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
On the Credit Facility Closing Date, the full $650.0 million amount of the Term Loan Facility was funded, and $550.0 million was funded under the Revolving Facility, which amounts were used, among other things, to refinance the outstanding obligations under the Prior Credit Facility.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
On February 28, 2025, we refinanced the Prior Credit Facility by using the proceeds of the Credit Facility to repay the outstanding balances of the Prior Term Loan Facility and the Prior Revolving Facility, which totaled $670.9 million and $485.0 million, respectively. In connection therewith, we recorded a loss on extinguishment of $1.3 million, which is included in debt extinguishment costs in the consolidated statements of operations.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
which $12.5 million was included in other accrued liabilities and $75.0 million was included in other long-term liabilities. We estimate receivables for the portion of professional and general liability reserves that are recoverable under our insurance policies. Such receivable was $28.8 million at December 31, 2025, of which $7.2 million was included in other current assets and $21.6 million was included in other assets, and such receivable was $9.3 million at December 31, 2024, of which $0.5 million was included in other current assets and $8.8 million was included in other assets.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
As of our annual impairment test on October 1, 2025, we had one reporting unit, behavioral healthcare services. In performing the goodwill impairment test, we used a combination of the income and market approaches to estimate the fair value of our reporting unit. Determining fair value requires substantial judgment and use of significant unobservable inputs, which are categorized as Level 3 fair value measurements. For the income approach, we used a discounted cash flow model in which cash flows are projected using internal forecasts over future periods, plus a terminal value, and are discounted to present value using a risk-adjusted rate of return. Our internal forecasts include estimates of growth rates and profitability based on our current views of the long-term outlook of the reporting unit and may materially differ from actual results. Discount rate assumptions are based on an assessment of the risk inherent in the projected future cash flows. For the market approach, we compared our reporting unit to guideline companies actively traded in public markets and included a control premium, which was based on acquisition premiums of selected companies similar to our reporting unit. These estimates and assumptions were determined in connection with support from a third-party valuation specialist. As of our annual impairment test on October 1, 2025, the fair value of our behavioral healthcare services reporting unit exceeded its carrying value, and therefore no impairment was recorded.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
During the fourth quarter of 2025, we revised our 2025 earnings forecast to reflect the impact of higher professional and general liability (“PLGL”) expenses associated primarily with patient-related litigation; lowered our internal revenue projections for future years to reflect changes in Medicaid reimbursement, primarily related to New York State exclusion of Medicaid referrals to our facilities in Pennsylvania; and experienced a sustained decline in our stock price and overall market capitalization. We concluded the combination of these factors constituted a triggering event which warranted a quantitative impairment test of our goodwill at December 31, 2025. We estimated the implied fair value of our goodwill using a combination of the income and market approaches,
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
as described above. The discounted cash flow model used in the income approach reflected our expectation of higher PLGL expenses and lower revenues and used a higher discount rate to correspond to the risks inherent in the reporting unit. The results of this analysis determined the fair value of our behavioral healthcare services reporting unit was less than its carrying value. Accordingly, we recorded a non-cash goodwill impairment charge of $996.2 million, representing the amount by which the Company’s book value exceeds its fair value, which is included in loss on impairment in the consolidated statement of operations.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
No goodwill impairment charges were recorded during the years ended December 31, 2024 or 2023.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
AddedMD&A
Assessment of the potential impairment of goodwill and intangible assets is an integral part of our normal ongoing review of operations. Testing for potential impairment of these assets is significantly dependent on numerous assumptions and reflects management’s best estimates at a particular point in time. In particular, estimating the fair value of our reporting unit includes substantial judgment and significant estimates and may materially differ from actual results. Changes in assumptions, industry or peer groups could negatively impact estimated fair value and impact the existence and magnitude of impairments, as well as the period in which such impairments are recognized. Impairment charges have no effect on liquidity or capital resources; however, they are a non-cash charge and could adversely affect our financial results in the period recognized.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RemovedMD&A
•our dependence on key management personnel, key executives and local facility management personnel;
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RemovedMD&A
states and Puerto Rico. During the year ended December 31, 2024, we added 776 beds, consisting of 312 added to existing facilities and 464 added through the opening of four wholly-owned facilities and one joint venture facility, and we opened nine CTCs.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RemovedMD&A
On November 7, 2022, we acquired four CTCs located in Georgia from Brand New Start.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RemovedMD&A
On January 18, 2024, we entered into the Second Amendment, which provided for the incurrence of $350.0 million of Incremental Term Loans. Such Incremental Term Loans are structured as an increase of the Term Loan Facility. The maturity date, the leverage-based pricing grid, mandatory prepayment events and other terms applicable to the Incremental Term Loans are substantially identical to those applicable to the initial $425.0 million term loans incurred under the Term Loan Facility. After giving effect to the Incremental Term Loans, the Credit Facility requires quarterly principal repayments for the Term Loan Facility of approximately $15.4 million for March 31, 2025, and $20.5 million for each quarter ending from June 30, 2025 to December 31, 2025. The remaining outstanding principal balance of the Term Loan Facility is due on the maturity date of March 17, 2026.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RemovedMD&A
As of the date of this Annual Report on Form 10-K, we are nearing completion of a syndication and closing process being led by JPMorgan Chase Bank, N.A. (“JPM”) for the replacement of the Revolving Facility and the Term Loan Facility with a new $1.0 billion, five-year senior secured revolving credit facility and a new $650 million, five-year senior secured term loan with JPM, as administrative agent, and a syndicate of lenders (the “Replacement Credit Facility”). JPM has provided us with a commitment for its allocated amount under the Replacement Credit Facility, and has received commitments from other lenders for the portion of the Replacement Credit Facility that will not be provided by JPM. While we currently expect to close the Replacement Credit Facility promptly after the filing of this Annual Report on Form 10-K, there can be no assurance that we will be able to complete any such transaction in that timeframe or at all.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RemovedMD&A
As of our annual impairment test on October 1, 2024, we had one reporting unit, behavioral healthcare services. The fair value of our behavioral healthcare services reporting unit substantially exceeded its carrying value, and therefore no impairment was recorded.
Read it in 10-K Feb 27, 2025 at sec.govopen_in_new
RewordedMD&A
Cash provided by financing activities for the year ended December 31, 2024 2025 primarily consisted of borrowings on long-term debt of $350.0 $1,200.0 million, borrowings on revolving credit facility of $305.0 $1,069.0 million and contributions from noncontrolling partners in joint ventures of $5.2 $8.6 million, offset by principal payments on long-term debt of $56.3 $12.2 million, principal payments on revolving credit facility of $15.0 $1,035.0 million, distributions to noncontrolling partners in joint ventures of $3.0 $3.9 million, repayment of long-term debt of $670.9 million, payment of debt issuance costs of $1.5 million and $18.6 million, repurchase of common stock of $50.0 million, repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises exercises, of $1.3 $4.2 million, and cash consideration paid of $1.5 million.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
In addition, the Credit Facility Agreement contains financial covenants requiring us to maintain, on a consolidated basis to maintain, as of the last day of any consecutive four fiscal quarter each quarterly period, a Consolidated Total Net Leverage Ratio of not more than 4.5 5.0 to 1.0 (which may be increased in connection with a material acquisition to 5.0 5.5 to 1.0 for a four quarter period of up to four consecutive fiscal quarters following three times during the consummation term of certain material acquisitions) the Credit Agreement) and a Consolidated Interest Coverage Ratio (as defined in the Credit Facility) Agreement) of at least 3.0 to 1.0.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Excluding equity-based compensation expense, Same facility SWB expense was $1,653.9 million, $1,587.3 million for the year ended December 31, 2025, or 52.4% 49.1% of revenue, compared to $1,499.1 million for the year ended December 31, 2024, compared to $1,540.0 million, or 52.6% 48.7% of revenue, for the year ended December 31, 2023. revenue.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
For the year ended December 31, 2024, 2025, the provision for income taxes was $26.0 million, reflecting an effective tax rate of (2.4)%, compared to the provision for taxes of $77.4 million, reflecting an effective tax rate of 22.6%, compared to the benefit from taxes of $(9.7) million, reflecting an effective tax rate of 38.2%, for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Same facility other operating expenses were $408.3 $500.9 million for the year ended December 31, 2025, or 15.5% of revenue, compared to $410.6 million for the year ended December 31, 2024, or 13.2% of revenue, compared to $361.8 million for the year ended December 31, 2023, or 12.6% 13.3% of revenue.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
A portion of our professional liability risks are insured through a wholly-owned insurance subsidiary providing coverage for up to $7.0 million per claim and $10.0 million for certain other claims through August 31, 2024 and $10.0 million per claim, $15.0 million per claim for certain other claims and $25.0 million for certain batched claims through August 31, 2025 and $15.0 million per claim and $25.0 million for certain batched claims thereafter.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Excluding equity-based compensation expense, SWB expense was $1,789.0 million, or 54.0% of revenue, for the year ended December 31, 2025, compared to $1,653.9 million, or 52.4% of revenue, for the year ended December 31, 2024, compared to $1,540.0 million, or 52.6% of revenue, for the year ended December 31, 2023. 2024.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Other operating expenses were $553.3 million for the year ended December 31, 2025, or 16.7% of revenue, compared to $440.8 million for the year ended December 31, 2024, or 14.0% of revenue, compared to $388.9 million for the year ended December 31, 2023, or 13.3% of revenue.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
Depreciation and amortization expense was $189.2 million for the year ended December 31, 2025, or 5.7% of revenue, compared to $149.6 million for the year ended December 31, 2024, or 4.7% of revenue, compared to $132.3 million for the year ended December 31, 2023, or 4.5% of revenue.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
We At December 31, 2025, we had $226.5 $594.8 million of availability under the Revolving Facility and had standby letters of credit outstanding of $3.5 $1.2 million related to security for the payment of claims required by our workers’ compensation insurance program at December 31, 2024. multiple development projects.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
During For the year ended December 31, 2024, 2025, we borrowed $305.0 $115.0 million on the Prior Revolving Facility and repaid $15.0 $485.0 million of the balance outstanding. outstanding prior to February 28, 2025, when the Prior Credit Facility was refinanced with the Credit Facility.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new
RewordedMD&A
The net adjustments to estimated cost report settlements resulted in a decrease to revenue of $0.7 million for the year ended December 31,2025 and an increase to revenue of $0.2 million, $1.8 million and $0.1 million $1.8 million, respectively, for the years ended December 31, 2024, 2023 2024 and 2022, respectively. 2023.
Read it in 10-K Feb 27, 2026 at sec.govopen_in_new